300888.SZ SHZ
Winner Medical Co., Ltd.
1W: -0.9%
1M: +1.0%
3M: +2.6%
YTD: -17.4%
1Y: -27.0%
3Y: -26.7%
5Y: -60.7%
¥29.25 ($4.36)
+0.37 (+1.28%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.3B
+37.2% ▲
5Y CAGR: +16.1%
Capital Expenditures
$901M
-19.6% ▼
5Y CAGR: +15.1%
Free Cash Flow
$558M
+80.0% ▲
5Y CAGR: +29.6%
Dividends Paid
$413M
+49.8% ▲
Buybacks
$195M
+0.0% ▲
Net Change in Cash
-$3.3B
-1183.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.8B | $1.2B | $1.7B | $580M | $695M |
| Depreciation & Amort. | $159M | $377M | $482M | $540M | $636M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $346M | -$769M | $423M | -$414M | -$268M |
| Other Non-Cash Items | $441M | $26M | $481M | $356M | $203M |
| Operating Cash Flow | $4.8B | $872M | $3.0B | $1.1B | $1.3B |
| — Investing Activities — | |||||
| Capital Expenditures | -$573M | -$743M | -$1.2B | -$753M | -$901M |
| Acquisitions (Net) | $820M | $191M | -$1.7B | -$147M | -$742M |
| Investment Purchases | -$8.4B | -$6.2B | -$9.2B | -$4.7B | -$6.0B |
| Investment Sales | $4.3B | $7.3B | $8.2B | $6.2B | $3.6B |
| Other Investing | -$573M | $0 | $63M | $342M | $0 |
| Investing Cash Flow | -$4.4B | $479M | -$3.8B | $1.0B | -$4.1B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$150M | $2.1B | -$683M | $212M |
| Stock Repurchased | $0 | -$258M | -$242M | $0 | -$195M |
| Dividends Paid | -$98M | -$768M | -$378M | -$822M | -$413M |
| Other Financing | $3.5B | -$492M | -$389M | -$281M | -$82M |
| Financing Cash Flow | $3.3B | -$1.4B | $1.1B | -$1.8B | -$478M |
| Net Change in Cash | $3.7B | -$61M | $282M | $307M | -$3.3B |
| Cash End of Period | $4.1B | $4.1B | $4.4B | $4.7B | $1.4B |
| Free Cash Flow | $4.2B | $128M | $1.8B | $310M | $558M |